Abstract Details
|
Rebecca O'Dwyer, MD
(Rush University Medical Center)
PRESENTER |
Dr. O'Dwyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. O'Dwyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Sciences. |
| No disclosure on file | |
| Steven Levine, MD, FAHA (SUNY Downstate Medical Center) | Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH. |
| No disclosure on file | |
| No disclosure on file | |
| Aashit K. Shah, MD, FAAN (Carilion Clinic) | Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma. |
| Richard C. Burgess, MD, PhD (Cleveland Clinic, Dept of Neurology) | Dr. Burgess has nothing to disclose. |